Product NDC: | 0168-0432 |
Proprietary Name: | imiquimod |
Non Proprietary Name: | imiquimod |
Active Ingredient(s): | 50 mg/g & nbsp; imiquimod |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0432 |
Labeler Name: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078548 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100225 |
Package NDC: | 0168-0432-24 |
Package Description: | 24 PACKET in 1 BOX (0168-0432-24) > .25 g in 1 PACKET (0168-0432-27) |
NDC Code | 0168-0432-24 |
Proprietary Name | imiquimod |
Package Description | 24 PACKET in 1 BOX (0168-0432-24) > .25 g in 1 PACKET (0168-0432-27) |
Product NDC | 0168-0432 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | imiquimod |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100225 |
Marketing Category Name | ANDA |
Labeler Name | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
Substance Name | IMIQUIMOD |
Strength Number | 50 |
Strength Unit | mg/g |
Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |